vs
Side-by-side financial comparison of Affinity Bancshares, Inc. (AFBI) and Cytosorbents Corp (CTSO). Click either name above to swap in a different company.
Cytosorbents Corp is the larger business by last-quarter revenue ($9.2M vs $8.6M, roughly 1.1× Affinity Bancshares, Inc.). Affinity Bancshares, Inc. runs the higher net margin — 24.9% vs -59.5%, a 84.4% gap on every dollar of revenue. On growth, Affinity Bancshares, Inc. posted the faster year-over-year revenue change (12.8% vs 0.9%). Affinity Bancshares, Inc. produced more free cash flow last quarter ($11.2M vs $-4.9M). Over the past eight quarters, Affinity Bancshares, Inc.'s revenue compounded faster (8.1% CAGR vs 1.3%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
AFBI vs CTSO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.6M | $9.2M |
| Net Profit | $2.1M | $-5.5M |
| Gross Margin | — | 73.7% |
| Operating Margin | 35.9% | -47.5% |
| Net Margin | 24.9% | -59.5% |
| Revenue YoY | 12.8% | 0.9% |
| Net Profit YoY | 58.5% | 27.4% |
| EPS (diluted) | $0.34 | $-0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $8.6M | $9.2M | ||
| Q3 25 | $8.4M | $9.5M | ||
| Q2 25 | $8.3M | $9.6M | ||
| Q1 25 | $7.8M | $8.7M | ||
| Q4 24 | $7.6M | $9.2M | ||
| Q3 24 | $8.0M | $8.6M | ||
| Q2 24 | $8.3M | $8.8M | ||
| Q1 24 | $7.3M | $9.0M |
| Q4 25 | $2.1M | $-5.5M | ||
| Q3 25 | $2.2M | $-3.2M | ||
| Q2 25 | $2.2M | $1.9M | ||
| Q1 25 | $1.8M | $-1.5M | ||
| Q4 24 | $1.3M | $-7.6M | ||
| Q3 24 | $1.7M | $-2.8M | ||
| Q2 24 | $1.0M | $-4.3M | ||
| Q1 24 | $1.3M | $-6.1M |
| Q4 25 | — | 73.7% | ||
| Q3 25 | — | 70.3% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 71.1% | ||
| Q4 24 | — | 68.4% | ||
| Q3 24 | — | 61.0% | ||
| Q2 24 | — | 73.5% | ||
| Q1 24 | — | 76.5% |
| Q4 25 | 35.9% | -47.5% | ||
| Q3 25 | 34.9% | -30.2% | ||
| Q2 25 | 34.1% | -37.6% | ||
| Q1 25 | 30.8% | -44.5% | ||
| Q4 24 | 21.1% | -37.1% | ||
| Q3 24 | 28.5% | -56.1% | ||
| Q2 24 | 16.2% | -40.4% | ||
| Q1 24 | 24.0% | -51.8% |
| Q4 25 | 24.9% | -59.5% | ||
| Q3 25 | 26.5% | -33.4% | ||
| Q2 25 | 25.9% | 20.2% | ||
| Q1 25 | 23.4% | -16.9% | ||
| Q4 24 | 17.7% | -82.7% | ||
| Q3 24 | 21.7% | -32.1% | ||
| Q2 24 | 12.5% | -48.6% | ||
| Q1 24 | 18.2% | -67.7% |
| Q4 25 | $0.34 | $-0.09 | ||
| Q3 25 | $0.34 | $-0.05 | ||
| Q2 25 | $0.33 | $0.03 | ||
| Q1 25 | $0.28 | $-0.02 | ||
| Q4 24 | $0.21 | $-0.14 | ||
| Q3 24 | $0.26 | $-0.05 | ||
| Q2 24 | $0.16 | $-0.08 | ||
| Q1 24 | $0.20 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $53.9M | $6.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $127.0M | $5.9M |
| Total Assets | $881.7M | $44.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.9M | $6.2M | ||
| Q3 25 | $84.8M | $7.5M | ||
| Q2 25 | $89.7M | $10.2M | ||
| Q1 25 | $74.7M | $11.6M | ||
| Q4 24 | $41.4M | $3.3M | ||
| Q3 24 | $52.3M | $5.7M | ||
| Q2 24 | $50.4M | $8.5M | ||
| Q1 24 | $61.4M | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $13.8M | ||
| Q2 24 | — | $13.7M | ||
| Q1 24 | — | $4.4M |
| Q4 25 | $127.0M | $5.9M | ||
| Q3 25 | $125.4M | $9.0M | ||
| Q2 25 | $124.1M | $11.6M | ||
| Q1 25 | $122.3M | $14.5M | ||
| Q4 24 | $129.1M | $11.1M | ||
| Q3 24 | $128.4M | $13.4M | ||
| Q2 24 | $125.1M | $17.4M | ||
| Q1 24 | $123.3M | $19.6M |
| Q4 25 | $881.7M | $44.2M | ||
| Q3 25 | $925.2M | $45.8M | ||
| Q2 25 | $933.8M | $48.0M | ||
| Q1 25 | $912.5M | $50.8M | ||
| Q4 24 | $866.8M | $47.4M | ||
| Q3 24 | $878.6M | $47.8M | ||
| Q2 24 | $873.6M | $53.4M | ||
| Q1 24 | $869.5M | $47.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.6M | $-4.8M |
| Free Cash FlowOCF − Capex | $11.2M | $-4.9M |
| FCF MarginFCF / Revenue | 130.9% | -53.4% |
| Capex IntensityCapex / Revenue | 4.9% | 1.2% |
| Cash ConversionOCF / Net Profit | 5.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $20.3M | $-12.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $-4.8M | ||
| Q3 25 | $3.7M | $-2.6M | ||
| Q2 25 | $3.8M | $-1.5M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $6.8M | $-2.3M | ||
| Q3 24 | $4.1M | $-2.5M | ||
| Q2 24 | $619.0K | $-4.8M | ||
| Q1 24 | $1.2M | $-4.8M |
| Q4 25 | $11.2M | $-4.9M | ||
| Q3 25 | $3.6M | $-2.6M | ||
| Q2 25 | $3.7M | $-1.5M | ||
| Q1 25 | $1.8M | $-3.5M | ||
| Q4 24 | $6.4M | $-2.4M | ||
| Q3 24 | $4.0M | $-2.6M | ||
| Q2 24 | $489.0K | $-4.8M | ||
| Q1 24 | $1.1M | $-4.9M |
| Q4 25 | 130.9% | -53.4% | ||
| Q3 25 | 43.3% | -27.3% | ||
| Q2 25 | 44.0% | -16.1% | ||
| Q1 25 | 22.7% | -39.7% | ||
| Q4 24 | 83.9% | -26.3% | ||
| Q3 24 | 49.5% | -30.4% | ||
| Q2 24 | 5.9% | -54.4% | ||
| Q1 24 | 14.8% | -54.2% |
| Q4 25 | 4.9% | 1.2% | ||
| Q3 25 | 0.8% | 0.2% | ||
| Q2 25 | 1.4% | 0.4% | ||
| Q1 25 | 1.9% | 0.0% | ||
| Q4 24 | 5.6% | 0.8% | ||
| Q3 24 | 1.7% | 1.8% | ||
| Q2 24 | 1.6% | 0.2% | ||
| Q1 24 | 1.8% | 0.5% |
| Q4 25 | 5.46× | — | ||
| Q3 25 | 1.66× | — | ||
| Q2 25 | 1.75× | -0.78× | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 5.05× | — | ||
| Q3 24 | 2.36× | — | ||
| Q2 24 | 0.60× | — | ||
| Q1 24 | 0.91× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AFBI
Segment breakdown not available.
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
